Cardiovascular

BIOTRONIK announced FDA clearance and availability of the Vital Data Sensor, which identifies body temperature increases potentially associated with fever, in the new BIOMONITOR...

Blackford, the pioneering strategic imaging AI platform and solutions provider, announces a partnership with Ligence Medical AI Solutions to make Ligence Heart available on...

When Mr. Prasad, a 55-year-old heart patient in need of a bypass, first heard of ‘robotic heart surgery', he assumed that it was only for...

Cordis, a worldwide leader in the development and manufacturing of interventional cardiovascular and endovascular technology, announced that it has completed the acquisition of MedAlliance,...

The results of the largest prospective study of patients-at-risk of Sudden Cardiac Arrest (SCA) in emerging countries – IMPROVE SCA – has revealed that...

Cardio Flow, a private medical device firm focusing in minimally invasive peripheral artery disease (PAD) treatments, has received FDA 510(k) clearance for its FreedomFlow...

Modern cardiac surgery owes its existence to technology as all other fields of medicine. Cardiac surgery with its various surgeries requires artificial valves, fabric grafts, Heart-Lung machine and its components and disposables, along with various other technological innovations in the ICU and in anaesthesia for successful outcomes.

MicroPort Cardio Rhythm Management (CRM) announced the first recruitment for the Astral-4LV clinical trial to evaluate the safety and efficacy of Axone, a left...

COVID-19 has affected global economy in three main ways. Firstly, by directly affecting production and demand, secondly by creating supply chain and market disruption, and thirdly by its financial impact on firms and financial markets. The global cardiovascular market continues to see rapid innovation with new drugs and devices entering the market. - Presented by Gopal Anand

India Medtronic Private Limited, a wholly owned subsidiary of Medtronic plc, a global leader in healthcare technology, announced the launch of Arctic Front™ Cardiac Cryoablation...

With the successful execution of the first-in-human telerobotic intervention, we are now opening new avenues and this is going to change the global scenario of telerobotic interventions. Dr. Tejas M. Patel, Chairman and Chief Interventional Cardiologist, Apex Heart Institute, Ahmedabad

In its effort to fight against COVID-19, the Ordnance Factory Board (OFB) has come up with a two-bed tent with necessary medical facilities that...

Edwards Lifesciences announced that the first patient has been treated, in the RESTORE clinical trial, which will evaluate the safety and effectiveness of the...

RhythMedix, a leader in remote cardiac monitoring released a next-generation RhythmStar wearable device with built-in 4G cellular connectivity. The novel cardiac telemetry monitor is...

Medcura, Inc., a commercial-stage medical device company, published the results of a peer-reviewed clinical study at the University of Chicago in this month's Cardiovascular...

Menstrual blood cells are unique; they multiply rapidly and can differentiate into many types of stem cells demonstrating great promise for future use in clinical regenerative medical therapies. Menstrual blood stem cell banking is the process of banking of menstrual blood for the purpose of cell therapy. - Mrs. Hema K

Dr. Beri, do share with us your vast experience in the healthcare domain, both as a clinician as well as a management professional.After...

Inovise Medical announced the U.S. Food and Drug Administration (FDA) has granted a device designation for its AUDICOR heart failure management system. The system...

With its continued commitment towards advance therapy adoption in intervention cardiology for treating Complex and High-risk Coronary Intervention (CHIP) patients, Boston Scientific has collaborated...

New integrated workflow improves valve sizing accuracy during aortic valve replacement procedures